Vimpat 100 MG tablet UD 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NL7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,193
Award facts
- Contract value 100% obligated
- $1,193.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of VIMPAT 100 mg tablets in unit dose packaging (60-count) with a firm fixed price of $1,193.48. This is a non-set-aside contract awarded on a competitive basis, with performance required by January 30, 2026, at the company's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and military treatment facilities. The company's extensive portfolio under its DLA IDC covers specialty medications, brand-name and generic pharmaceuticals, vaccines, and other medical supplies across multiple therapeutic domains. VIMPAT (lacosamide) is an antiepileptic medication used in neurological treatment applications, consistent with the range of therapeutic products supplied through the prime vendor contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F9NL7?
SPE2DR26F9NL7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9NL7 worth?
The government has obligated $1,193 on SPE2DR26F9NL7.
Is contract SPE2DR26F9NL7 an order under another contract?
Yes. SPE2DR26F9NL7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NL7 competed?
The extent of competition for SPE2DR26F9NL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award